Investor Relations - Old just for save

Evogene Ltd. (Nasdaq, TASE: EVGN) is a pioneering computational chemistry company developing generative AI to design and optimize small molecules for the pharmaceutical and agricultural industries.

Latest Press Releases

Press releases

24.06.2026

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

Press releases

09.06.2026

Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Press releases

02.06.2026

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

Presentations

Download PDF

16.06.2026

Latest Financial Results

Q1 2026 EARNINGS CALLS

Earnings Call Presentation

20.05.2026

Financial Results

20.05.2026

Press Release

Sign Up for Investor Relations Email Alerts

Investor Relations Contact

Ofer Haviv
President and CEO

IR@evogene.com

+972-8-9311900

Evogene Ltd.
Pioneering Real-World Innovation in Computational Chemistry for Pharma & Agriculture

Latest Press Releases

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

Latest Financial Results

Q1 2026 EARNINGS CALLS

Earnings Call Presentation

Financial Results

Sign Up for Investor Relations Email Alerts

Investor Relations Contact

Ofer Haviv
President and CEO

Our website uses cookies to provide optimal performance and improve your viewing experience. Please accept cookies to continue.

Evogene Ltd. Pioneering Real-World Innovation in Computational Chemistry for Pharma & Agriculture

Latest Press Releases

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

Latest Financial Results

Q1 2026 EARNINGS CALLS

Earnings Call Presentation

Financial Results

Sign Up for Investor Relations Email Alerts

Investor Relations Contact

Ofer Haviv President and CEO

Evogene Ltd.
Pioneering Real-World Innovation in Computational Chemistry for Pharma & Agriculture

Ofer Haviv
President and CEO